Brief: OSE Immunotherapeutics Appoints Laurence De Schoulepnikoff As CBO
21/12/2021 17:16
Dec 21 (Reuters) - OSE Immunotherapeutics SA OSE.PA :
* OSE IMMUNOTHERAPEUTICS STRENGTHENS LEADERSHIP TEAM WITH
THE
APPOINTMENT OF LAURENCE DE SCHOULEPNIKOFF AS CHIEF BUSINESS
OFFICER
Source text for Eikon: ID:nGNXwSd9P
Further company coverage: OSE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO